Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Palladium Catalyzed Asymmetric Allylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116478081A reveals novel monodentate phosphine ligands for palladium-catalyzed asymmetric allylation. Achieve high enantioselectivity and yield for reliable pharmaceutical intermediate supply chains.
Novel axial chiral phosphine-ene ligand enables high-yield asymmetric allylation with mild conditions, reducing manufacturing costs and lead times for fine chemicals.